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ABSTRACT
Casposons are a recently discovered group of large
DNA transposons present in diverse bacterial and ar-
chaeal genomes. For integration into the host chro-
mosome, casposons employ an endonuclease that
is homologous to the Cas1 protein involved in proto-
spacer integration by the CRISPR-Cas adaptive im-
mune system. Here we describe the site-preference
of integration by the Cas1 integrase (casposase) en-
coded by the casposon of the archaeon Acidulipro-
fundum boonei. Oligonucleotide duplexes derived
from the terminal inverted repeats (TIR) of the A.
boonei casposon as well as mini-casposons flanked
by the TIR inserted preferentially at a site reconsti-
tuting the original A. boonei target site. As in the A.
boonei genome, the insertion was accompanied by a
15-bp direct target site duplication (TSD). The mini-
mal functional target consisted of the 15-bp TSD seg-
ment and the adjacent 18-bp sequence which com-
prises the 3′ end of the tRNA-Pro gene correspond-
ing to the TC loop. The functional casposase target
site bears clear resemblance to the leader sequence-
repeat junction which is the target for protospacer
integration catalyzed by the Cas1–Cas2 adaptation
module of CRISPR-Cas. These findings reinforce the
mechanistic similarities and evolutionary connection
between the casposons and the adaptation module
of the prokaryotic adaptive immunity systems.
INTRODUCTION
Most of the archaea and many bacteria possess an adap-
tive immune system, the CRISPR (Clustered Regularly In-
terspaced Palindromic Repeats)-Cas (CRISPR-associated
proteins) system, whose role is to neutralize invading
foreign DNA of viral or plasmid origin (1,2). This is
achieved by maintaining an archive of fragments that are
derived from previously encountered foreign genomes (3).
These fragments are subsequently transcribed into an RNA
molecule that, after processing, ends up as a guide for a dis-
tinct complex of Cas proteins which then recognizes and de-
grades further invadingDNAs bearing the same (or in some
case, closely related) sequence (for reviews see refs. (1,4–9)).
The library of foreign DNA fragments is located in the
genome at the CRISPR locus, in which the fragments are
integrated as spacers between identical, often palindromic,
repeats of about 25–50 bp each (CRISPR) (9,10). Integra-
tion of new fragments is carried out by a complex that con-
sists of the twomost conserved Cas proteins, Cas1 andCas2
(2,11) and in some cases, includes additional Cas proteins
as well (12–15). Spacers are integrated at the 5′ end of the
CRISPR array, resulting in duplication of the correspond-
ing repeat (for recent reviews see refs (16,17)). The integrase
activity of Escherichia coli Cas1 has been characterized in
vitro (18). Cas1 has been shown to promote the integration
of a synthetic, double-stranded spacer into a target plasmid.
This reaction is strongly stimulated byCas2 and occurs only
with supercoiled target DNA unless integration host fac-
tor (IHF) is additionally supplied (19,20). When the target
plasmid contained a CRISPR locus, the spacer was inserted
preferentially at the border of the CRISPR array although
some integration was also observed in the control plasmid
pUC19 not bearing such repeats. In the latter case, however,
the preferred site of integration was located in the vicinity
of an inverted repeat with a potential to form a cruciform
structure, suggesting that, as with bona fide CRISPR, such
structures are important for spacer integration (18,21). It
has been further shown that Cas1 alone displays sequence-
specific activity, with a clear preference for the nucleotides
flanking the integration site at the leader-repeat 1 boundary
of the CRISPR locus, suggesting that the inherent sequence
specificity of Cas1 is a major determinant of the adapta-
tion process (11,22,23). The Cas1–Cas2 machinery is at the
heart of the adaptation process and is considered to be the
hallmark of the prokaryotic CRISPR-Cas immunity (1,2).
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However, how the adaptation machinery and the specificity
of protospacer incorporation at the leader-proximal repeat
boundary have evolved remains largely unknown.
Most of the cas1 genes identified in sequenced genomes
belong to CRISPR-Cas systems; however, some Cas1 ho-
mologs are encoded outside of the CRISPR loci and are
not associated with other cas genes (24,25). Instead, these
genes appear to be part of clusters that always additionally
include genes for family B DNA polymerases and a vari-
able complement of other genes, including, in some cases,
Cas4-like nucleases, another widespread component of the
CRISPR-Cas systems (1,25), as well as other nucleases (24).
These clusters are delimited by terminal inverted repeats
(TIR) which themselves are flanked by direct repeats typ-
ical of the target site duplications (TSD) resulting from fill-
in repair of the single-strand gaps generated upon staggered
nick-mediated integration of various transposons (26–28).
Consequently, we hypothesized that these gene clusters rep-
resent a novel group of transposons, dubbed casposons to
emphasize the conservation of the Cas1 homologs and their
likely involvement in transposition (24). Notably, the TIRs
of some casposons show sequence and secondary struc-
ture similarity (i.e. palindromic organization) with certain
CRISPR repeats. Based on these observations and phylo-
genetic analysis of Cas1 proteins, it has been proposed that
the adaptationmodule of the CRISPR-Cas systems evolved
from casposons (29). Although less common than many
other families of transposons, casposons are present in both
bacterial and archaeal genomes and are classified into four
families based on the gene content and casposase phylogeny
(30).
The integrase activity of the Cas1 protein encoded in
the casposon ofAciduliprofundum boonei, hereinafter called
casposase, has been demonstrated in vitro (31). The recom-
binant casposase was able to incorporate a 5′-labeled fluo-
rescent oligonucleotide duplex consisting of the 26 terminal
nucleotides of the TIR into the pUC19 plasmid. Integration
proceeded by transesterification leading to the formation of
a new phosphodiester bond between the 3′ end of the in-
coming duplex and the target strand of the plasmid, and to
nicking of the plasmid. As a result of the nicking, the su-
percoiled form of the plasmid was converted to the relaxed
form. A second nicking and integration event occurring on
the opposite strand in the close proximity of the first one
then linearized the plasmid (Supplementary Figure S1) (31).
The reaction displayed a strong specificity for the distal
part of the TIR borne by the incoming DNA. Such speci-
ficity contrasts the case of CRISPR system, in which the
only documented preference concerning the protospacer se-
quence in the subtype IE CRISPR-Cas system of E. coli
appears to involve the 3′ terminal cytidine that is comple-
mentary to the G of the AAG protospacer adjacent mo-
tif (PAM) that is required both for protospacer acquisition
and for targeting the cognate foreign DNA (18,32). Even
more prominent difference between theA. boonei casposase
and CRISPR Cas1 was that, in contrast to protospacer in-
tegration by CRISPR Cas1, casposon integration by the
casposase seemed to display little specificity with respect
to the site of insertion of the incoming casposon. How-
ever, this lack of specificity was deduced from the results
of integration experiments performed with pUC19, a plas-
mid that carries no similarity to the sequences that flank
the original casposon in the A. boonei genome. In contrast,
recent comparative genomic analysis of a large collection
ofMethanosarcina mazei strains provided the first evidence
of intra-genomic mobility of these elements and indicated
that casposon integration is sequence-specific in vivo (33).
These observations prompted us to re-examine the insertion
specificity of the A. boonei casposase. To this end, we used
a target plasmid carrying the regions flanking the caspo-
son in the A. boonei genome and identified the site of inte-
gration of two substrates corresponding to the pre-cleaved
casposon ends. These substrates were, respectively, a fluo-
rescent oligonucleotide duplex matching the distal end of
the casposon TIR and an artificial casposon consisting of a
kanamycin resistance gene flanked by TIRs on both sides.
The target site of the casposase identified through this ap-
proach resembles the target for protospacer integration cat-
alyzed by the Cas1–Cas2 adaptation module of CRISPR-
Cas, thus reinforcing the mechanistic similarity between the
casposons and CRISPR-Cas which presumably stems from
the evolutionary link between the two.
MATERIALS AND METHODS
Strains and plasmids
The lists of strains and plasmids used in this study are
summarized in Supplementary Tables S1 and 2. A codon-
optimized version of the sequence encoding the casposase
of A. boonei was ordered from GeneArtTM (a subsidiary
of Thermo Fisher Scientific). The gene, including the stop
codon, was recloned between the Klenow-filled NcoI and
the XhoI sites of the pETM-11, generating the pETM-
11-Cas1 plasmid. The plasmid was then introduced into
SoluBL21(DE3)TM (amsbio) bearing the pDIA17 plasmid
(34)
The pMA-Target plasmid was ordered fromGeneArtTM.
It comprises the region extending from nt 380 184 to
nt 380 323 fused with the region extending from nt
389 415 to nt 389 539 of the genome sequence of A.
boonei T469 (accession n◦CP001941.1). Thus, the synthe-
sized segment includes a single copy of the duplicated
target site CCCCACTACGAGGAG flanked by the ad-
jacent 125 nt on either side (Figure 1). This DNA seg-
ment is inserted between the SacI and KpnI sites of the
pMA plasmid (map available from the Thermofisher web
site: https://www.thermofisher.com/content/dam/LifeTech/
Documents/geneart/geneart-vector-map.pdf).
The pMA-Target plasmid was constructed by digest-
ing pMA-Target with NcoI and KpnI, followed by polish-
ing the ends with Klenow DNA polymerase and recircular-
izing the vector, thus removing most of the A. boonei se-
quence. Other plasmids carrying deletions of pMA-Target
were constructed by polymerase chain reaction (PCR) am-
plification of pMA-Target using divergent primers flanking
the region to be deleted and carrying either SacI or KpnI
extensions. The amplified segments were then gel-purified,
digested with the corresponding enzymes plus DpnI to de-
stroy the original template, and recircularized. The pMA-
Target plasmid and its derivatives were introduced into
TOP10 chemically competent cells (Invitrogen).
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Figure 1. Structure of the insert borne by pMA-Target. TIR: terminal inverted repeat; DNAP; DNAP: PolB-like DNA polymerase; HNH: HNH nuclease;
HTH: helix-turn-helix protein; MTase: methyl transferase; TSD: TSD segment. The TIR, TSD and the tRNA-Pro gene are not drawn to scale.
The pMA-Abooneicasp-kana plasmid was designed by
inserting the kanamycin resistance gene of pET28, preceded
by its promoter and followed by a T7 terminator, between
the 36-bp left and right TIR of the A. boonei casposon. The
plasmid then served as a template for the PCRamplification
of the minicasposon encoding kanamycin resistance.
Production and purification of the casposase
A 1-L culture of SoluBL21(DE3)(pDIA17)(pETM-11-
Cas1) was started at 30◦C in 2YT medium containing 30
g/ml kanamycin and 30 g/ml chloramphenicol. The
growth of the culture was followed by monitoring the
OD600. When the OD600 reached 0.9–1.1, the culture was
chilled for 5 min in a 13◦C water bath, followed by induc-
tion with IPTG at a final concentration of 1 mM. After fur-
ther incubating the culture overnight with shaking at 14◦C,
cells were centrifuged and the pellets kept at −80◦C until
processing.
The frozen pellet from a 1-L culture was resuspended in
20 ml buffer 1 (50 mM NaHPO4 pH 7.8 containing 1.2 M
NaCl, 20 mM imidazole (neutralized to pH 8) and two pel-
lets of protease inhibitor cocktail (Roche cOmplete Ultra
mini R©). Cells were ruptured by two passages with a French
press set at 100 MPa and the crude extract was centrifuged
for 30 min at 35 000 g. The supernatant was loaded on a
column containing 1.5 ml Ni-NTA (Qiagen) equilibrated
with the same buffer (but without protease inhibitors) and
washed with several volumes of the same buffer. Remaining
nucleic acids retained by the casposase were washed at room
temperature with 5 column volumes of buffer 2 (50 mM
Tris–HCl buffer pH 8 containing 4.75MNaCl), followed by
three volumes of buffer 1 and four volumes of buffer 3 (same
as buffer 1 except 35 mM imidazole). The purified protein
was eluted with 50 mM NaHPO4 pH 7.8 containing 1.2 M
NaCl and 300 mM imidazole. Eluted fractions containing
the protein were dialyzed against 50 mM Tris–HCl pH 8
containing 0.8 MNaCl and concentrated by ultrafiltration.
In order to remove the N-terminal His-tag, which consisted
of the sequence MKHHHHHHPMSDYDIPTTENLYFQ,
part of the preparation (2mg)was treated over night at 25◦C
with 1.6 mg His-tagged Tev protease in 4 ml 50 mM Tris-
HCl pH 8 containing 0.5 MNaCl, 1 mM dithiothreitol and
0.25 mM ethylenediaminetetraacetic acid (EDTA). The de-
tagged protein, which carried the two residuesGAupstream
of the original initiation methionine of Cas1, was separated
from the tagged polypeptides (cleaved His-tag, tagged Tev
protease and remaining His-tagged casposase) by passage
over a 1.5 ml Ni-NTA column equilibrated with buffer 1.
Unbound fractions were collected, concentrated by ultrafil-
tration, buffer was exchanged against 25 mM Tris–HCl pH
7.5 containing 0.5 M NaCl and 15% (v/v) glycerol and the
preparation stored at −20◦C.
Integration of a fluorescent oligonucleotide duplex
The integration of a fluorescent oligonucleotide duplex
was performed as described in (31). Briefly, 200 nM of ds
oligonucleotide formed by hybridizing LE26 and 6-FAM-
labeled LE26r (Supplementary Table S3) was incubated for
1 h at 37◦C in 100 l Tris–HCl 25 mM containing 150 mM
KCl, 5mMMnCl2, 50g/ml bovine serum albumin (BSA),
1.5 g/ml plasmid DNA and various concentrations of A.
boonei casposase carrying or not an N-terminal His tag.
The reaction was stopped by adding 25 mM EDTA (fi-
nal), and the reaction was digested for 1 h with 60 g pro-
teinase K 30 u/mg (Eurobio, Paris). Nucleic acids were pre-
cipitated with ethanol in the presence of glycogen and 0.3
M sodium acetate, pH 5, washed with 70% ethanol, resus-
pended in 10 mM Tris–HCl, 1 mM EDTA, pH 8, heated
at 65◦C for 5 min and run on a 1% agarose gel in 1 ×
TBE (Tris/Borate/EDTA). Electrophoresis equipment was
soaked in 2.6%hypochlorite to destroy any remaining ethid-
ium bromide. The integration of the fluorescent duplex into
the relaxed and linearized form of the plasmids was visual-
ized on a GE Typhoon FLA 9500 imager.
Integration of a mini-casposon encoding kanamycin resis-
tance
A mini-casposon containing a kanamycin resistance gene
flanked by the 37-bp TIR from A. boonei was generated
by PCR using primers LE41 and RE41 and pMA-Casp-
kana as a template. The product was treated with DpnI
and gel-purified to eliminate the template. Integration reac-
tions were performed as described by Hickman and Dyda
(31). Four g/ml mini-casposon was incubated over night
at 37◦C in 100l Tris–HCl 25mMcontaining 150mMKCl,
5mMMnCl2, 50g/ml BSA, 1.5g/ml plasmidDNA and
75 nM A. boonei casposase carrying or not an N-terminal
His tag. Reaction products were column purified using the
Macherey Nagel Gel and PCR purification kit, precipitated
with ethanol and resuspended in 8 l water. Two micro-
liter were used to electroporate 20 l of ElectroMax E. coli
DH10B cells (ThermoFisher) as directed by the supplier.
Cells were plated on carbenicillin plus kanamycin plates.
The sites of integration of the casposon were determined by
isolating the plasmids borne by the transformants and se-
quencing casposon boundaries with the divergent primers
533r and Seq3.
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RESULTS
Insertion of the TIR-derived oligonucleotide duplex into
pMA-Target and pMA-target
To investigate the specificity of casposon integration, we
compared the integration of the 6-FAM-labeled LE26 du-
plex, which matches the distal part of the left TIR of
the A. boonei casposon, into plasmids pMA-Target and
pMA-Target. The pMA-Target plasmid carries a syn-
thetic DNA segment that reconstitutes the target region of
integration of the A. boonei casposon, with a single copy of
the TSD segment flanked on each side by 125 bp of the orig-
inal A. boonei chromosomal sequence. This segment was
deleted in the pMA-Target plasmid. A. boonei casposase
had been shown to perform both single and double-ended
integration of the LE26 duplex into pUC19 in vitro, gener-
ating fluorescently labeled relaxed and linear forms of the
plasmid, respectively (31).
Figure 2A shows that, in agreement with previous find-
ings (31), the de-tagged enzyme is able to generate the tan-
dem integration of the duplex regardless of the presence or
absence of the target sequence. In these reactions, labeled
linearized forms of both pMA-Target and pMA-Target
were generated. However, in the absence of the target se-
quence, (lanes 7–12), integration of the 6-FAM-tagged du-
plex was considerably less efficient.
Strikingly, when the reactionwas performedwith theHis-
tagged enzyme (Figure 2B), the tandem integration of the
labeled LE26 duplex occurred exclusively in the presence of
the A. boonei target site, as in pMA-Target. In contrast, in-
tegration in pMA-Target was less efficient and led almost
exclusively to the relaxed form, indicating either single in-
tegration events or, possibly, double-ended integrations oc-
curring at distantly located sites.
In order to locate the site of double-ended integration on
pMA-Target, we performed the integration reaction with
His-tagged casposase and pMA-Target DNA that had been
pre-digested with ApaLI. ApaLI generates a 1393 nt frag-
ment that carries the target site and a 1246 nt fragment that
does not, thus single integration at the target site is expected
to label the 1393 fragment, while tandem integration should
yield two further fragments of 758 and 635 nt. Figure 3B
confirms these predictions. Furthermore, it demonstrates
that A. boonei casposase is able to perform integration on
linear DNA, unlike the E. coli CRISPR Cas1–Cas2 com-
plex (18).
We then sought to determine whether single integration
of an oligonucleotide duplex by casposase proceeds with a
preference for a specific strand of the plasmid. For this, we
incubated pMA-Target with the de-tagged casposase in the
presence of the LE32 duplex which matches the distal end
of the left TIR. We then purified the relaxed form, corre-
sponding to single-site integration, and subjected it to PCR
amplification using the primers LE32r + 1179 or LE32r +
1737r (Supplementary Table S3). Samples were taken at dif-
ferent cycles of amplification and analyzed by agarose gel
electrophoresis. Given that 1179 and 1737r hybridize to op-
posite strands of pMA-Target (Figure 3), the appearance of
a defined fragment in either PCR implies that a single inte-
gration of the LE32 duplex has occurred at a specific site on
the opposite strand.
Figure 3 shows two salient findings. First, there is clearly
a preferential, but not exclusive integration site that yields
defined fragments of about 1700 bp in the case of the PCR
performedwith LE32r + 1179 and 1500 bp in the case of the
PCR performed with LE32r + 1737r. The length of these
fragments corresponds to the length expected for integra-
tion of the duplex at the target site, i.e. 1718 and 1512 bp,
respectively. Second, Figure 3 also shows that the two frag-
ments appear and increase in the amount concomitantly
and with the same intensity at each increasing number of
PCR cycles. This result indicates that a single integration of
the duplex preferentially occurs at the defined target site on
both strands with little or no strand preference.
Insertion of an artificial casposon encoding kanamycin resis-
tance
In their recent study, Hickman and Dyda (31) described an
artificial mini-casposon with a kanamycin resistance gene
flanked by the 15 or 30 distal bp of the left and right TIR of
theA. boonei casposon. Thesemini-casposons were success-
fully integrated by the casposase into the pUC19 plasmid.
Mapping and sequencing of the integration sites has shown
that integration consistently involved duplication of a 14- or
15-bp sequence from the target site but occurred essentially
randomly, with neither sequence signature nor orientation
preference (31).
Given the specificity of TIR-derived duplex integration
into the native target site, we tested the insertion specificity
of the artificial mini-casposon consisting of a kanamycin re-
sistance gene flanked by the full-length (37 bp) left and right
TIRs from the genome of A. boonei. A summary of the re-
sults is presented in Tables 1 and 2, and the details of each
clone can be found in Supplementary Tables S4 and 5.
When performing the reaction with de-tagged casposase
and pMA-Target, in four of the nine tested clones, inser-
tion occurred at the A. boonei native target site with a du-
plication of the adjacent 15-bp segment, hereafter the TSD
segment (Table 1 and Supplementary Table S4). In the re-
maining five clones, integration occurred randomly at sites
remote from the A. boonei target site. This finding is consis-
tent with the result of the LE32 duplex integration: Figure
3C shows a defined band arising from integration at the tar-
get site, which is surrounded by a background likely reflect-
ing random integration at other sites.
When the His-tagged casposase was used to integrate the
mini-casposon into pMA-Target, in 26 of the 28 clones, the
mini-casposon was found inserted at the original target site
reconstituted from theA. boonei genome, with a duplication
of the 15-bp TSD segment. At variance with the original A.
boonei sequence, an additional T was found in most cases
between the upstream TSD segment and the beginning of
the casposon TIR, and an A was found between the other
end of the casposon and the downstream TSD (Supplemen-
tary Table S4). Most likely, the presence of these extra nu-
cleotides is an artefact of PCR amplification with the Taq
DNA polymerase, which is known to add a 3′-terminal A
via its nucleotidyltransferase activity (35). Two clones were
also identified in which casposon insertion did not result in
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Figure 2. Integration by the Aciduliprofundum boonei casposase of the 6-FAM-labeled LE26 duplex into pMA-Target and pMA-Target. (A) Integration
by de-tagged casposase. Integration of the 6-FAM-labeled LE26 duplex (200 nM) was monitored as described in ‘Materials andMethods’ section using 1.5
g/ml pMA-Target (lanes 1–6) or pMA-Target (lanes 7–12) and increasing concentrations of de-tagged Cas1: 15 nM (lanes 1 and 7), 20 nM (lanes 2 and
8), 30 nM (lanes 3 and 9), 40 nM (lanes 4 and 10), 60 nM (lanes 5 and 11) and 75 nM (lanes 6 and 12). The gel was scanned to visualize integration of the
fluorescent duplex (top panel) followed by staining with ethidium bromide (bottom panel). Rel, Lin and CCC: relaxed, linear and covalently closed, circular
forms of the plasmids, respectively. (B) Integration by His-tagged casposase. Integration of the 6-FAM-labeled LE26 duplex (200 nM) was monitored as
described in ‘Materials and Methods’ section using 1.5 g/ml pMA-Target (lanes 1–6) or pMA-Target (lanes 9–14) and increasing concentrations of
His-tagged Cas1: 0 nM (lanes 1 and 9), 15 nM (lanes 2 and 10), 30 nM (lanes 3 and 11), 45 nM (lanes 4 and 12), 70 nM (lanes 5 and 13) and 100 nM (lanes
6 and 14). In lanes 7 and 15, each plasmid was incubated with 100 nM Cas1, but no duplex. pMA-Target and pMA-Target linearized with SacI were
loaded in lanes 8 and 16, respectively. After visualizing the 6-FAM fluorescence of the integrated duplex (top panel), the gel was stained with ethidium
bromide (bottom panel). Similar results were obtained in two independent experiments.
Table 1. Modes of integration of a mini-casposon encoding kanamycin resistance into pMA-Target catalyzed by tagged and de-tagged Cas1
Enzyme De-tagged Cas1 Tagged Cas1
Number of clones
recovered
129 ± 34a (2)b 59 ± 19a (4)b
Total number of clones
sequenced
9 28
Site of insertion Insertion at the A. boonei
target site
Insertion outside of the A.
boonei target site
Insertion at the A. boonei
TSD
Insertion outside of the A.
boonei target site
Number of clones
sequenced
4 clones 5 clones 26 clones 2 clones
Size of TSD at insertion
site
15 bp (2 clones)
4 bp (2 clones)
16 bp (1 clone)
15 bp (1 clone)
Unstable (1 clone)
Deletion (2 clones)
15 bp (26 clones) 22 bp (1 clone)
deletion (1 clone)
anumber of clones ± standard deviation recovered per independent experiment.
bnumber of independent experiments (insertion + transformation).
Following transformation and selection for resistance to kanamycin, transformants were picked randomly and the regions flanking the left and right TIR
were sequenced to determine the site of integration and the extent of sequence duplication occurring at the target site.
duplication of the TSD. In one of these, the casposon was
inserted at a different site andwas flanked by a 22-bp repeat;
in the other one, one end of the casposon was flanked by
the A. boonei TSD segment, whereas the other end was in-
serted at a position located 288 bp upstream from the TSD
segment (Table 1 and Supplementary Table S4).
The de-tagged casposase was then used to catalyze the
integration of the mini-casposon into pMA-Target. The
recovery of recombinant clones was about 50–60% of that
obtained with pMA-Target. There was no obvious prefer-
ence regarding the site of insertion, which seemed to occur
randomly, consistent with the previous results (31). Thema-
jority (seven out of nine) of the clones tested displayed a re-
iteration of 13–15 bp flanking the casposon; however, two
casposons were flanked by much larger reiterations of 155
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Figure 3. Determination of the site and strand of integration of the LE32 duplex. (A) Map of the pMA-Target plasmid and of expected PCR fragments (see
panelC). The target region in shown in red, with the TSD segment in green; the LE32 and LE32r oligonucleotides are shown in black and blue, respectively;
the PCR fragments generated in reactions 1 and 2 are in brown and purple, respectively. (B) Integration by His-tagged casposase of 6-FAM labeled LE-26
duplex into ApaLI-digested pMA-Target. Fifteen ng/l ApaLI-digested pMA-Target was incubated for 1 h at 37◦C in a total volume of 100 l reaction
buffer with 200 nM 6-FAM labeled LE-26 duplex and 75 nM His-tagged casposase. The reaction mixture was treated with proteinase K, precipitated and
analyzed as described in ‘Materials and Methods’ section. Similar results were obtained for four independent incubations. The two unlabeled bands with
slower migration seen in the ethidium bromide stain correspond to undigested closed circular and relaxed DNAmolecules that did not undergo integration
of the 6-FAM duplex. (C) Identification the strand bearing the integrated duplex upon single integration events. A preparative integration reaction was
set up by incubating 450 ng of pMA-Target together with 200 nM LE32 duplex and 320 nM de-tagged Cas1 in a total volume of 300 l reaction buffer
for 95 min at 37◦C. The relaxed form of pMA-Target was gel-purified and subjected to two PCR reactions with different pairs of primers: reaction 1 was
performed with primers LE32r and 1179 and reaction 2 with primers LE32r and 1737r. Samples were withdrawn at the end of the elongation step at defined
cycles of amplification from either PCR reaction and subjected to agarose gel electrophoresis. Integration revealed by amplification in reactions 1 and 2
were defined as occurring in strand + and −, respectively. The expected sizes of amplified fragments for integration at the TSD site are 1718 and 1512 bp
for reactions 1 and 2, respectively (panel A).
Table 2. Modes of integration catalyzed by tagged and de-tagged Cas1 into pMA-Target of a mini-casposon encoding kanamycin resistance
Enzyme De-tagged Cas1 Tagged Cas1
Number of clones recovered 80 ± 22a (3)b 2 ± 1.8a (4)b
Number of clones sequenced 9 clones 8 clones
Size of TSD at insertion site 13 bp (1 clone)
14 bp (3 clones)
15 bp (3 clones)
155 bp (1 clone)
1421 bp (1 clone)
3 bp (1 clone)
14 bp (2 clones)
15 bp (3 clones)
546 bp (1 clone)
1802 bp (1 clone)
anumber of clones ± standard deviation recovered per independent experiment.
bnumber of independent experiments (insertion + transformation).
Following transformation and selection for resistance to kanamycin, transformants were picked randomly and the regions flanking the left and right TIR
were sequenced to determine the site of integration and the extent of sequence duplication occurring at the target site.
and 1421 bp, respectively (Table 2 and Supplementary Table
S5).
When the His-tagged casposase was used to integrate
the mini-casposon into pMA-Target, the efficiency of in-
sertion declined by an order of magnitude. The integra-
tion sites were located randomly; in addition, although
five of the eight sequenced clones contained 14–15 bp re-
peats flanking either side of the casposon, three clones were
flanked by repeats ranging from 3 to 1802 bp (Table 2 and
Supplementary Table S5), indicating a less stringent appli-
cation of the ‘15 bp yardstick’. No transformants were ob-
tained when the reaction was performed in the absence of
the enzyme, excluding the possibility that the observed inte-
grations were the result of illegitimate recombination events
taking place in E. coli.
Regardless of the substrate plasmid or the casposase
preparation, in 52 of the 58 sequenced recombinant plas-
mids, insertion occurred such as to yield the same orienta-
tion for the kanamycin resistance gene borne by the mini-
casposon and the ampicillin resistance gene borne by the
plasmid. This uniformity is likely due to the selection by
the host, which was plated with both antibiotics, and to
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the ability of the casposon to switch orientation by recom-
bination between the TIRs. Indeed, PCR with appropriate
primers demonstrated that single colonies contained both
orientations but in such different proportions that sequenc-
ing nonetheless yielded a non-ambiguous result.
Determination of the target sequence required for recognition
by the casposase
In order to delimit the minimum segment recognized by the
casposase, we made use of the fact that the target sequence
is essential for double-ended integration of the fluorescent
LE26 duplex by His-tagged casposase, which generates the
labeled, linear form of the plasmid. We thus generated a
set of deletions in the pMA-Target and tested the incorpo-
ration of the duplex, as shown in Figure 4 A and B. The
results are summarized in Figure 4C. The 15-bp TSD seg-
ment, where the two DNA strands are nicked, was insuffi-
cient to support tandem integration of LE26. Whereas the
sequence downstream of the TSD segment was dispensable,
the upstream region was strictly essential for integration.
The shortest fragment tested that still bears the recognition
sequence includes the 15-bp TSD segment and an 18-bp ad-
jacent segment.
An interesting feature of the A. boonei TSD segment is
that it overlaps with the 3′ end of a gene encoding tRNA-
Pro by 5-bp (Figure 4D). The 103–140 segment (Figure 4C)
essential for casposon integration includes the segment cor-
responding to the TC loop of the tRNA.
DISCUSSION
The previous study on the A. boonei casposase has shown
that the protein catalyzes non-sequence-specific integration
of mini-casposons and generates TSD in the process (31).
As confirmed in the present work, this is indeed what hap-
pens when a plasmid lacking the specific target site is used
as a substrate for integration reactions. More specifically,
we detected tandem integration into plasmids of a fluo-
rescent oligonucleotide duplex corresponding to the distal
part of the TIR; likewise, an artificial casposon contain-
ing a kanamycin resistance gene flanked by TIRs was in-
tegrated with the concomitant generation, in most cases, of
a 15 ± 2 nt duplication at the integration site. When per-
formed with a plasmid that lacked the original target region
fromA. boonei, these reactions displayed no obvious prefer-
ence regarding the site of integration. Importantly, however,
here we show that when the original A. boonei target site is
present, this site is strongly preferred for integration by the
casposase. In addition, the version of the enzyme contain-
ing a His-tag was almost incapable of performing tandem
integration in the absence of the target site, thus display-
ing, somewhat surprisingly, an enhanced target specificity
compared to the de-tagged, native form. The nature of this
effect of the His-tag has not been directly addressed; con-
ceivably, the concentration of the de-tagged casposase used
in the experiments was sufficient to oversaturate the gen-
uine, high affinity target site and lead to binding and in-
tegration into other, low-affinity random sites. Decreasing
the affinity of the casposasewould prevent oversaturation of
the specific site and occupation of the non-specific sites. The
present demonstration that the casposase shows consider-
able specificity toward the native integration sites is fully
consistent with the comparative genomic findings which in-
dicate that casposon integration in methanogenic archaea
occurs in a sequence-specific manner (33). Interestingly, vir-
tually all known site-specific recombinases belong to one of
only two superfamilies, the tyrosine recombinases and the
serine recombinases (36,37). Casposases andCRISPRCas1
belong to neither of these groups and thus can be considered
to represent the third superfamily of recombinases with pre-
ferred integration sites.
Integration by A. boonei casposase typically generates a
duplication of the 15-bp TSD segment (plus or minus one
or two nucleotides). However, in some cases, mini-casposon
integration resulted from staggered transesterifications lo-
cated at sites separated by distances widely differing from
the 15-bp ‘yardstick’. These events were detected only when
integration occurred outside of the canonical target site. A
scenario compatible with these observations could be that
the casposase binds to DNA and, while bound to a particu-
lar site, performs concerted transesterifications at sites sep-
arated by 15 bp. The A. boonei casposase has been shown
to behave as a dimer in solution (31), as also is the case for
CRISPR Cas1 in the absence of Cas2 (38,39). The dimer
configuration provides a pair of catalytic sites poised for
concerted reactions at a specific distance. However, if the in-
teraction between casposase and DNA is weakened, the en-
zyme could dissociate before both reactions are completed.
This would prevent linearization of the plasmid; further-
more, in cases when the complex binds again randomly to a
second site, integrations would lead to duplications of ran-
dom sizes. In this scenario, two factors would influence the
stability of the functional interaction between the casposase
and DNA. One is the target sequence: the enzyme displays
a high, specific affinity for the segment reconstituted from
theA. boonei integration site, making it a strongly preferred
target for integration. Another one would be the presence of
the N-terminal His-tag, which would destabilize the inter-
action. This would explain why the tagged enzyme is nearly
incapable of performing the linearization of the plasmid un-
less the A. boonei target sequence is present; it would also
account for the random size duplications observed when in-
tegration occurs outside of the canonical target site. The
same effects likely would have been observed if the presence
of the target sequence or the His-tag were to increase or de-
crease, respectively, the rates of both concerted integration
reactions.
As a site-preferring integrase, A. boonei casposase re-
sembles CRISPR Cas1, which also shows a strong prefer-
ence for sites adjacent to CRISPR palindromic repeats (18).
In the case of the A. boonei casposase, the target site in-
cludes the palindromic repeat formed by the sequence en-
coding the TC loop of tRNA-Pro. However, the pres-
ence of a palindrome potentially able to form a cruciform
structure is unlikely to be the only factor that determines
the site of integration. The segment 82–125, which includes
the TC loop, but not the 15-bp region corresponding to
the TSD, is not a functional target (Figure 4), and nor is
the segment 126–265, which includes another palindrome,
AGTCCCCCTTTGGGACT, that potentially could form a
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Figure 4. Functional mapping of the region required for tandem integration of the LE26 duplex by His-taged Cas1. (A and B) Integration of the 6-FAM-
labeled LE26 duplex (200 nM) was monitored as described in ‘Materials and Methods’ section with either 35 or 70 nM His-tagged casposase and 1.5
g/ml of plasmids harboring various deletions of the target segment borne by pMA-Target. The concentration of the casposase and the borders of each
target site are indicated above each lane.A: gel scanned for 6-FAM fluorescence; B, same as A, after ethidium bromide staining. (C) Diagram summarizing
the results obtained for the tandem integration of the 6-FAM-labeled LE26 duplex using the plasmids mentioned in Table 2. The TSD segment is shown
in green. (D) Structure of the tRNA encoded by the region upstream of the Aciduliprofundum boonei TSD segment. Arrows indicate the position of the
tRNA gene and its intron relative to the insert of pMA-Target and of features such as the beginning of the TSD or the beginning of the insert borne by the
pMA-T103-140 plasmid. Numbering starts at the beginning of the insert borne by pMA-Target. The Figure was drawn using the software available online
and described in ref. (45).
hairpin loop of greater stability than that of the TC loop
(40).
Notably, the sequence features of the casposon target site
are functionally similar to those required for directional in-
sertion of new protospacers into CRISPR arrays (Figure 5).
In both systems, the functional target site consists of two
components: (i) a sequence which gets duplicated upon in-
tegration of the incoming DNA duplex (i.e. the TSD seg-
ment in the case of casposon and a CRISPR unit during
protospacer integration) and (ii) the upstream region which
further determines the exact location of the integration (i.e.
the leader sequence located upstream of the CRISPR ar-
ray (11,22,23) and the 18-bp segment encoding the TC
loop of tRNA-Pro in A. boonei). Directional integration of
the protospacers at the leader-repeat 1 boarder is an im-
portant property of the CRISPR-Cas systems. The cata-
log of CRISPR repeats provides a sequential historical ac-
count of prior encounters between the host and mobile ge-
netic elements (41). Similarly, the inherent features of the
target site would in principle allow multiple casposon inte-
grations in tandem, each new casposon being inserted up-
stream of the previous one, and every casposon being sep-
arated from its neighbors by a TSD segment. Such tandem
casposon arrays have been indeed identified in the genomes
of certain Methanosarcina species (33). Thus, the insertion
of casposons appears to be deeply similar to the insertion
of CRISPR spacers, which further emphasizes the evolu-
tionary relationships between the two systems. However, in
spite of clear structural and functional similarities, they also
display notable differences. In particular, the spacers inte-
grated by the CRISPR Cas1–Cas2 complex have a defined
size and are generally short, ranging between 26 and 72
bp (9), whereas the casposase was able to integrate a 1024-
bp artificial casposon whose only similarity to the original
 at Institut Pasteur M
ediathÃ¨que Scientifique on October 20, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2016 9
required for integration
3'-OH
HO-3'
O
O
3'-OH
HO-3'
5'3'
3'5' 5'
5'
3'
3'
3'-OH
HO-3'
O
O
3'-OH
HO-3'
5'3'
3'5' 5'
5'
3'
3'
Leader
new spacer
casposon
TIR
Repeat 1
required for integration
Spacer Repeat 2 tRNA
Preintegration locus
TSD segment
First nucleophilic attack 
at the leader-repeat or 
tRNA-TSD border
Half-site intermediate
Second attack at the 
repeat or TSD border
Double-ended
integration
DNA repair and repeat
or TSD duplication
CRISPR spacer integration Casposon integration
Figure 5. Comparison of models of CRISPR spacer (left) and casposon (right) integration. The first nucleophilic attack occurs at the leader-repeat or the
tRNA-TSD segment border by the 3′-OH end of the spacer or the casposon, respectively. After the formation of the half-site intermediate, the second
nucleophilic attack occurs on the opposite strand at the repeat-spacer border (for CRISPR spacer) or at the junction between the TSD segment and the
flanking DNA, distal to the tRNA gene (for casposon). The resulting single-stranded DNA gaps are repaired by uncharacterized mechanisms. The left
panel has been modified from ref (19).
9.1 kb casposon of A. boonei included the two TIRs. Fur-
thermore, integration of casposons is strictly dependent on
the sequence of the distal ends of the TIRs (31), whereas
in the E. coli CRISPR-Cas system, the specificity of in-
corporation of new spacers into CRISPR loci is limited to
single nucleotide originating from the adjacent PAM mo-
tif (18,42). In this respect, A. boonei casposase resembles
other transposases, which also recognize TIR (reviewed in
ref (26)). Another difference is that integration by the A.
boonei casposase does not depend on the DNA conforma-
tion and can proceed with linear DNA (Figure 3 and ref.
(31)), whereas the CRISPR Cas1–Cas2 complex requires
a supercoiled target plasmid, unless bending of the tar-
get DNA is effected by the IHF (19). Finally, no homolog
of CRISPR Cas2 has yet been identified within the cas-
posons described so far. Investigating the crystal structure
ofA. boonei casposase, particularly in complex with its sub-
strates, will enable detailed comparison with the CRISPR-
Cas structures (20,43,44) and shed light on the differences
and further similarities between the two systems. Such com-
parison will also provide crucial information on the fea-
tures that determine the recognition specificity of the caspo-
son TIR and of the integration target site. It is to be noted
that for both systems, only the integration reaction so far
has been amenable to successful in vitro dissection whereas
the excision of CRISPR spacers or of casposons from their
original locations still awaits a similar development.
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